Argenx
ARGX
#505
Rank
NZ$84.90 B
Marketcap
NZ$1,359
Share price
-3.69%
Change (1 day)
40.55%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company